While its expression is moderate, MR was found to be expressed widely in all breast cancer subtypes, with the highest positivity in normal-like (93%), luminal A (75%) and basal-like (74%) breast cancers (Supplementary Fig. S3D). The gene discussed is NR3C2; the disease is breast carcinoma.